Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New strategies for bone marrow transplantation.

S Slavin1

  • 1Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem, Israel. slavin@cc.huji.ac.il

Current Opinion in Immunology
|September 28, 2000
PubMed
Summary

Nonmyeloablative stem-cell transplantation (NST) is optimal for adoptive immunotherapy and inducing transplantation tolerance. This approach facilitates mixed chimerism, crucial for treating various diseases and enabling organ allografts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reactivity of Human Monoclonal Antibody Campath-1 with Human Leukemia Lymphoma Cell Lines of Varying Maturation.

Leukemia & lymphoma·2016
Same author

Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy.

AIDS and behavior·2014
Same author

Total lymphoid irradiation.

Immunology today·2014
Same author

Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individuals.

Current molecular medicine·2013
Same author

Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis.

Bone marrow transplantation·2012
Same author

Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses.

Bone marrow transplantation·2011

Area of Science:

  • Immunology
  • Hematology
  • Transplantation Science

Background:

  • Adoptive immunotherapy using donor lymphocyte infusion is effective for hematologic malignancies and metastatic solid tumors.
  • Inducing host-versus-graft tolerance is key for successful donor lymphocyte infusion.
  • Nonmyeloablative stem-cell transplantation (NST) offers a promising strategy for tolerance induction.

Purpose of the Study:

  • To evaluate NST as the optimal approach for adoptive immunotherapy and transplantation tolerance.
  • To explore the role of mixed chimerism in achieving tolerance to donor alloantigens.
  • To identify potential applications of NST in nonmalignant diseases.

Main Methods:

  • Nonmyeloablative stem-cell transplantation (NST) was employed to induce tolerance.

Related Experiment Videos

  • Mixed chimerism was induced to achieve tolerance to donor alloantigens.
  • The efficacy of NST was assessed for various therapeutic indications.

    • Main Results:

    • NST facilitates the induction of host-versus-graft tolerance.
    • Mixed chimerism is an effective strategy for inducing tolerance to donor alloantigens.
    • NST shows potential for treating nonmalignant conditions.

    Conclusions:

    • NST is the optimal approach for adoptive immunotherapy and inducing transplantation tolerance.
    • Mixed chimerism is crucial for successful tolerance induction.
    • NST holds significant promise for treating genetic deficiencies, autoimmune diseases, infectious diseases, and facilitating organ allografts.